- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06617702
Accountability Support Through Peer-Inspired Relationships and Engagement (ASPIRE) Trial (ASPIRE)
July 14, 2025 updated by: Brian Suffoletto, Stanford University
ASPIRE to Change: Leveraging Text Messaging Peer Support Coaching to Mitigate Hazardous Alcohol Consumption in Non-Collegiate Young Adults
This project aims to test the efficacy of a text message intervention, ASPIRE, designed to address cognitive and behavioral elements and modify exposure to peers that influence drinking behaviors.
Young adults who are contemplating reducing their drinking will be recruited from a national sample and randomized to ASPIRE versus a text message intervention focused solely on cognitive and behavioral elements.
We will measure effectiveness at 3, 6, and 12 months, study mechanisms driving behavior change, and identify which subgroups stand to benefit most.
Study Overview
Status
Recruiting
Conditions
Study Type
Interventional
Enrollment (Estimated)
300
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Brian Suffoletto, MD, MS
- Phone Number: 4129016892
- Email: suffbp@stanford.edu
Study Locations
-
-
California
-
Palo Alto, California, United States, 94306
- Recruiting
- Stanford University
-
Contact:
- Brian Suffoletto Associate Professor, MD, MS
- Phone Number: (650)-723-5244
- Email: aspirestudy@stanford.edu
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Age 18-25 years (verified using date of birth)
- Lives in the U.S. (based on zip code)
- English reader (verified based on completing screen)
- 2+ days with ≧4 standard alcohol drinks for women or ≧5 standard alcohol drinks for men in past month
- Owns a mobile phone with SMS (verified by texting enrollment procedure)
Exclusion Criteria:
- Currently enrolled or past enrollment in a 4-year college
- Active military
- Pregnant or pregnancy plans in the next 12-months
- Prisoner status
- Current or planned treatment for alcohol or substance use disorder in next 12-months
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: A text message alcohol intervention focused on cognitive, behavioral, and peer influences
|
Each Thursday and Sunday ASPIRE will conduct brief text message communication aimed at modifying cognitive (e.g.desire to get drunk), behavioral (e.g.alcohol consumption), and peer influences (e.g.peer pressure and support).
|
|
Active Comparator: A text message alcohol intervention focused on cognitive and behavioral influences
|
Each Thursday and Sunday ASPIRE will conduct brief text message communication aimed at modifying cognitive (e.g.
desire to get drunk) and behavioral (e.g.
alcohol consumption) influences.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Number of Binge Drinking Days (BDD)
Time Frame: 3, 6, and 12 months
|
We define BDD as a day when a woman reports 4 or more standard drinks or a man reports 5 or more standard drinks, as this equates to the alcohol consumption that raises blood alcohol concentration to 0.08 g/dl or above.
|
3, 6, and 12 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Negative Alcohol Consequences (NAC) Scale Score
Time Frame: 3, 6 and 12 months
|
We calculate the number of NAC using the Brief Young Adult Alcohol Consequences Questionnaire (B-YAACQ).
The B-YAACQ is a 24-item measure of alcohol-related problems that utilizes a dichotomous (present or absent) scoring format.
Higher scores indicate both wider variety and more severe pattern of alcohol-related problems.
|
3, 6 and 12 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Brian Suffoletto, MD, Stanford University
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Kahler CW, Hustad J, Barnett NP, Strong DR, Borsari B. Validation of the 30-day version of the Brief Young Adult Alcohol Consequences Questionnaire for use in longitudinal studies. J Stud Alcohol Drugs. 2008 Jul;69(4):611-5. doi: 10.15288/jsad.2008.69.611.
- Sobell LC, Brown J, Leo GI, Sobell MB. The reliability of the Alcohol Timeline Followback when administered by telephone and by computer. Drug Alcohol Depend. 1996 Sep;42(1):49-54. doi: 10.1016/0376-8716(96)01263-x.
- Rueger SY, Trela CJ, Palmeri M, King AC. Self-administered web-based timeline followback procedure for drinking and smoking behaviors in young adults. J Stud Alcohol Drugs. 2012 Sep;73(5):829-33. doi: 10.15288/jsad.2012.73.829.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
April 7, 2025
Primary Completion (Estimated)
July 31, 2026
Study Completion (Estimated)
May 31, 2027
Study Registration Dates
First Submitted
September 26, 2024
First Submitted That Met QC Criteria
September 26, 2024
First Posted (Actual)
September 27, 2024
Study Record Updates
Last Update Posted (Actual)
July 17, 2025
Last Update Submitted That Met QC Criteria
July 14, 2025
Last Verified
July 1, 2025
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 76956
- 1R01AA030986-01A1 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
YES
IPD Plan Description
All test message and web-based data from baseline through 12-month followups will be uploaded to the data repository (the National Institute on Alcohol Abuse and Alcoholism Data Archive (NIAAADA).
IPD Sharing Time Frame
Data will be available within 1 year of study completion and available indefinitely.
IPD Sharing Access Criteria
Individuals can request access to study data through the NIAAADA.
If there are data from the trial not submitted to the NIAAADA , investigators can submit an abstract of their research question to the PI and study investigators for review.
The written data request abstract will include the researcher's resume and qualifications (including a statement of any conflicts of interest), an outline of the analysis aims, analysis methods, variables requested, data to be analyzed, proposed product of the request (e.g., conference presentation, manuscript) and timeline for completion.
The PIs and study investigators will review the data request abstract, and approve or decline the data request.
Individuals whose data request is approved are asked to sign a confidentiality and data sharing agreement prior to receipt of any study data.
The investigator making the request must obtain approval from their institution's IRB to conduct the proposed analyses.
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Alcohol Consumption
-
The University of Hong KongActive, not recruitingExcessive Alcohol ConsumptionHong Kong
-
Centre for Addiction and Mental HealthUniversity of HoustonCompleted
-
Centre for Addiction and Mental HealthCanadian Institutes of Health Research (CIHR)CompletedAlcohol Consumption | Hazardous Alcohol ConsumptionCanada
-
Wayne State UniversityCompleted
-
Institut national de prevention et d'education...CompletedHazardous Alcohol Consumption
-
International Agency for Research on CancerUniversidad de Murcia; Federico II University; University of Tromso; Imperial College... and other collaboratorsCompletedNo Condition, Focus: Metabolites of Alcohol Consumption
-
Denver Health and Hospital AuthorityMcNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc.CompletedModerate Alcohol Consumption (1-3 Drinks Per Day)
-
University of WashingtonNational Institutes of Health (NIH); National Institute on Aging (NIA); Seattle...Active, not recruitingMild to Heavy Alcohol ConsumptionUnited States
-
Jordi Gol i Gurina FoundationSocietat Catalana de Medicina Familiar i Comunitària (CAMFIC); Associació Catalana... and other collaboratorsUnknownAlcohol Consumption | Traffic Accident | Risk Perception of Driving After Alcohol ConsumptionSpain
-
Technische Universität DresdenCharite University, Berlin, GermanyCompletedHigh-risk Alcohol Consumption Pattern | Low-risk Alcohol Consumption PatternGermany
Clinical Trials on A text message alcohol intervention focused on cognitive, behavioral, and peer influences
-
University of WashingtonThe Hope FoundationActive, not recruitingInsomnia | Anatomic Stage I Breast Cancer AJCC v8 | Anatomic Stage II Breast Cancer AJCC v8 | Anatomic Stage III Breast Cancer AJCC v8United States